FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular, to a method for selecting a recipient during cadaver kidney transplantation, including the detection of antigens HLA-A, HLA-B and HLA-DR, comparison of epitopes of HLA-A and HLA-B antigens of a potential recipient and donor, as well as the choice of recipient according to the obtained data.
EFFECT: invention allows to optimize the selection of a donor-recipient pair, providing an increase in the life of the graft.
1 cl, 2 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF GRAFT KIDNEY GRAFT REJECTION | 2018 |
|
RU2688172C1 |
| METHOD OF SELECTING RECIPIENT IN CASE OF CORPSE KIDNEY TRANSPLANTATION | 2010 |
|
RU2425625C1 |
| METHOD FOR PREVENTING CADAVER KIDNEY GRAFT REJECTION | 2011 |
|
RU2456615C1 |
| METHOD FOR TREATING CHRONIC HEPATITISES OR HEPATIC CIRRHOSIS CASES | 2006 |
|
RU2295351C1 |
| METHOD FOR ASSESSING THE RISK OF FORMATION OF ANTI-HLA ANTIBODIES DURING TRANSFUSION OF BLOOD COMPONENTS | 2022 |
|
RU2793843C1 |
| METHOD FOR DETERMINING HEMATOPOIETIC CHIMERISM IN THE STUDY OF SINGLE NUCLEOTIDE POLYMORPHISMS OF GENES MTHER: 677, MTHER: 1298, MTR: 2756, MTRR: 66 | 2017 |
|
RU2667127C1 |
| METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE, OR MYOCARDIAL INFARCTION AND ITS AFTEREFFECTS, OR CEREBRAL ISCHEMIA INDUCED BY ATHEROSCLEROSIS OR ACUTE DYSFUNCTION OF CEREBRAL CIRCULATION, AND ITS AFTEREFFECTS, OR ATHEROSCLEROSIS-INDUCED ISCHEMIA OF INFERIOR LIMBS | 2005 |
|
RU2284190C1 |
| DIAGNOSTICUM FOR IDENTIFYING DONOR-SPECIFIC MAJOR HISTOCOMPATIBILITY COMPLEX ANTIBODIES AND METHOD FOR PREPARING IT | 2012 |
|
RU2491552C1 |
| METHOD FOR DETERMINING POSTTRANSPLANTATION CHIMERISM IN ANALYSIS OF POINT MUTATIONS OF BASE SUBSTITUTION IN GENES F2, F5, F7, F13, FGB, ITGA2, ITGB3, PAI-1 | 2017 |
|
RU2667006C1 |
| METHOD FOR DETERMINING POSTTRANSPLANTATION CHIMERISM IN COURSE OF STUDY OF ABO SYSTEM ERYTHROCYTE ANTIGENS | 2020 |
|
RU2758064C1 |
